Medical management of Crohn's disease.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed.

1. Saudi Arabia consensus guidance for the diagnosis and management of adults with inflammatory bowel disease.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association · 2022
   Article
2. Mild Abdominal Trauma Complicated With Bowel Perforation in Patient With Crohn's Disease: Clinical and Intraoperative Findings.Cureus · 2022
   Article
3. Attenuation of Excess TNF-α Release in Crohn's Disease by Silencing of iRHOMs 1/2 and the Restoration of TGF-β Mediated Immunosuppression Through Modulation of TACE Trafficking.Frontiers in immunology · 2022
   Article
4. Acute Granulomatous Appendicitis and Lower Gastrointestinal Bleeding as the Presenting Features of Crohn's Disease.Cureus · 2019
   Article
5. Market share and costs of biologic therapies for inflammatory bowel disease in the USA.Alimentary pharmacology & therapeutics · 2018
   Article
6. Impact of Biologic Treatment of Crohn's Disease on the Rate of Surgeries and Other Healthcare Resources: An Analysis of a Nationwide Database From Poland.Frontiers in pharmacology · 2018
   Article
7. Dietary treatment of Crohn's disease: perceptions of families with children treated by exclusive enteral nutrition, a questionnaire survey.BMC gastroenterology · 2017
   Article
8. Health Insurance Paid Costs and Drivers of Costs for Patients With Crohn's Disease in the United States.The American journal of gastroenterology · 2016
   Article
9. TNF-Journal of immunology research · 2016
   Article
10. Management of arthropathy in inflammatory bowel diseases.Therapeutic advances in chronic disease · 2015
    Review
11. Cost savings of anti-TNF therapy using a test-based strategy versus an empirical dose escalation in Crohn's disease patients who lose response to infliximab.Journal of market access & health policy · 2015
    Article
12. CCR9 antagonism: potential in the treatment of Inflammatory Bowel Disease.Clinical and experimental gastroenterology · 2015
    Review
13. Immunosuppressive therapies for inflammatory bowel disease.World journal of gastroenterology · 2014
    Review
14. Improving outpatient services: the Southampton IBD virtual clinic.Frontline gastroenterology · 2012
    Review
15. Sleep disturbances and inflammatory bowel disease: a potential trigger for disease flare?Expert review of clinical immunology · 2011
    Review
16. An unusual presentation of fistulating Crohn's disease: Ascites.World journal of gastrointestinal endoscopy · 2010
    Article
17. Abdominal pain in an adult with Type 2 diabetes: A case report.Cases journal · 2008
    Article
18. A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease.Journal of medicine and life
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as